or Try an Advanced Search...

    Technical Analysis for ALBT - Avalon GloboCare Corp.

    Grade Last Price % Change Price Change
    F 2.94 -6.07% -0.19
    ALBT closed down 6.07 percent on Friday, November 1, 2024, on 80 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ALBT trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Fell Below 20 DMA Bearish -6.07%
    Wide Bands Range Expansion -6.07%
    NR7 Range Contraction -11.71%
    Narrow Range Bar Range Contraction -11.71%
    Upper Bollinger Band Walk Strength -11.71%
    Wide Bands Range Expansion -11.71%
    Fell Below 50 DMA Bearish -10.64%
    Volume Surge Other -10.64%
    Older End-of-Day Signals for ALBT ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 1 day ago
    Down 5% 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 10% 1 day ago
    20 DMA Resistance 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ALBT Chart by TradingView
    Basic chart:

    Profile

    Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
    Classification
    Sector: Healthcare
    Industry: Medical Care
    Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles

    Is ALBT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales
    Oct 25 Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
    Oct 25 EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer
    Oct 24 Avalon GloboCare announces 1-for-15 reverse stock split as part of Nasdaq compliance plan
    Oct 24 Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan
    Oct 9 Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device
    Aug 14 Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
    Aug 14 EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device
    Jul 31 Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
    Jul 18 Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
    See more ALBT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.6
    52 Week Low 2.424
    Average Volume 124,491
    200-Day Moving Average 5.13
    50-Day Moving Average 3.51
    20-Day Moving Average 3.18
    10-Day Moving Average 3.25
    Average True Range 0.61
    RSI (14) 37.11
    ADX 23.68
    +DI 22.16
    -DI 29.38
    Chandelier Exit (Long, 3 ATRs) 2.77
    Chandelier Exit (Short, 3 ATRs) 4.26
    Upper Bollinger Bands 3.84
    Lower Bollinger Band 2.53
    Percent B (%b) 0.31
    BandWidth 41.06
    MACD Line -0.07
    MACD Signal Line -0.11
    MACD Histogram 0.0371
    Fundamentals Value
    Market Cap 32.34 Million
    Num Shares 11 Million
    EPS -0.93
    Price-to-Earnings (P/E) Ratio -3.16
    Price-to-Sales 4.16
    Price-to-Book 7.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.81
    Resistance 3 (R3) 3.83 3.55 3.67
    Resistance 2 (R2) 3.55 3.33 3.55 3.62
    Resistance 1 (R1) 3.25 3.19 3.11 3.23 3.57
    Pivot Point 2.97 2.97 2.91 2.97 2.97
    Support 1 (S1) 2.67 2.75 2.53 2.65 2.31
    Support 2 (S2) 2.39 2.61 2.39 2.26
    Support 3 (S3) 2.09 2.39 2.22
    Support 4 (S4) 2.07